Data showed improvements in an objective measure of impaired eye movement associated with Parkinson’s disease, with a correlation between ...
Knight Therapeutics Inc. announced it had received expedited regulatory approval under ANVISA?s rare disease pathway for NIKTIMVO® (axatilimab), for the treatment of chronic graft-versus-host disease ...
Conversation log with AI from September 2026📖Approx. 13,000 characters📗ChatGPT-Luna-🕊️【Tori】I saw an expression saying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results